IMARC Group, a leading market research company, has recently releases report titled “Preclinical Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,” The study provides a detailed analysis of the industry, including the global preclinical imaging market share, size, trends, and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights:
How big is the preclinical imaging market?
The global preclinical imaging market size reached US$ 3.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.0 Billion by 2032, exhibiting a growth rate (CAGR) of 2.97% during 2024-2032.
Factors Affecting the Growth of the Preclinical Imaging Industry:
- Advancements in imaging technologies:
Advancements in imaging technologies represent a significant driver of the preclinical imaging market. Innovations in modalities such as magnetic resonance imaging (MRI), positron emission tomography (PET), single-photon emission computed tomography (SPECT), computed tomography (CT), optical imaging, and ultrasound have vastly improved the resolution, sensitivity, and accuracy of preclinical imaging. These technological advancements allow for more detailed visualization of biological processes at the molecular and cellular levels. For instance, the development of multimodal imaging systems, which combine different imaging techniques, enables researchers to obtain comprehensive data by simultaneously capturing anatomical, functional, and molecular information, aiding the market growth.
- Increased investment in research and development:
Increased investment in research and development (R&D) by pharmaceutical and biotechnology companies, as well as academic institutions, is another key factor driving the preclinical imaging market. The push for novel drug development, personalized medicine, and understanding complex diseases has led to a surge in preclinical studies. Significant funding is allocated to the development and validation of new imaging agents, probes, and contrast materials that enhance the specificity and sensitivity of imaging techniques. Moreover, government grants and public-private partnerships support large-scale preclinical research projects, facilitating the advancement of imaging technologies and their applications, thus bolstering the market demand.
- The growing demand for non-invasive imaging techniques:
The growing demand for non-invasive imaging techniques is a major driver of the preclinical imaging market. Non-invasive methods offer significant advantages over traditional invasive techniques, such as reducing the need for surgical procedures and minimizing harm to subjects. Non-invasive imaging allows for longitudinal studies where the same subjects can be imaged multiple times over a period, providing valuable insights into disease progression, treatment efficacy, and biological processes. This is particularly important in drug development, where the ability to monitor therapeutic effects and pharmacodynamics in vivo is crucial. Non-invasive imaging techniques also enable the study of live animals, preserving the natural physiological conditions and leading to more accurate and translatable findings contributing to the market expansion.
Request for a sample copy of this report: https://www.imarcgroup.com/preclinical-imaging-market/requestsample
Preclinical Imaging Market Report Segmentation:
Breakup by Product:
- Modality
- Optical Imaging Systems
- Preclinical Nuclear Imaging Systems
- Micro-Ultrasound Systems
- Micro-MRI Systems
- Micro-CT Systems
- Preclinical Photoacoustic Imaging Systems
- Preclinical Magnetic Particle Imaging (MPI) Systems
- Reagent
- Preclinical Optical Imaging Systems
- Preclinical Nuclear Imaging Reagents
- Preclinical MRI Contrast Agents
- Preclinical Ultrasound Contrast Agents
- Preclinical CT Contrast Agents
- Service
Based on the product, the market is segmented into modality (optical imaging systems, preclinical nuclear imaging systems, micro-ultrasound systems, micro-MRI systems, micro-CT systems, preclinical photoacoustic imaging systems, and preclinical magnetic particle imaging (MPI) systems), reagent (preclinical optical imaging systems, preclinical nuclear imaging reagents, preclinical MRI contrast agents, preclinical ultrasound contrast agents, and preclinical CT contrast agents), and service.
Breakup by End Use:
- Biotech Companies
- Pharmaceutical Companies
- Research Institutes
Biotech companies account for the majority of shares due to their extensive focus on drug discovery and development, which heavily relies on advanced preclinical imaging techniques.
Breakup By Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America enjoys the leading position due to the presence of major pharmaceutical companies, advanced research infrastructure, and substantial funding for biomedical research.
Global Preclinical Imaging Market Trends:
The increasing prevalence of chronic diseases necessitates extensive biomedical R&D of new therapies, strengthening the market growth. In line with this, the integration of artificial intelligence (AI) and machine learning (ML) in imaging analysis is enhancing data accuracy and accelerating the research process, providing an impetus to the market growth. Besides this, the rising focus on personalized medicine, requiring precise imaging to tailor treatments, and the expanding applications of imaging in stem cell research, which demands detailed visualization of cell differentiation and tracking in vivo, are supporting the market expansion.
Who are the key players operating in the industry?
The report covers the major market players including:
- Aspect Imaging Ltd.
- AXT PTY LTD
- Bruker Corporation
- FUJIFILM Visualsonics, Inc. (Fujifilm Holdings Corporation)
- LI-COR Biosciences
- Mediso Ltd.
- MILabs B.V. (Rigaku Corporation)
- MR Solutions Ltd.
- PerkinElmer, Inc.
- Photon etc.
- TriFoil Imaging
Ask Analyst & Browse the full report with TOC and list of Figures: https://www.imarcgroup.com/request?type=report&id=10802&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
